Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- The Global Impact Factor (GIF)
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Tetsuya Ozeki
Department of Pharmaceutical Sciences, Hoshi University, Tokyo, Japan
Biography
Dr. Tetsuya Ozeki is a prominent professor at the Graduate School of Pharmaceutical Sciences at Nagoya City University, Japan. He specializes in drug delivery systems (DDS) and nano-pharmaceutics, focusing on innovative therapeutic approaches. His work includes research on targeted nanoparticles for treating brain tumors, tuberculosis, and cancer, as well as systems for regenerating bone tissue and improving the solubility of water-insoluble drugs.
Publications
-
Short Communication
Pharmaceutical Care in the Digital Age: Telemedicine's Role in Enhancing Medication Access and Safety
Author(s): Tetsuya Ozeki*
Other relevant publications from this author
-
- Development of two-step sustained-release PLGA/hyaluronic acid gel formulations for intra-articular administration, focusing on improving therapeutic outcomes for knee conditions?
. - Fabrication of mucoadhesive oral films via 3D printing, aimed at personalized therapy and enhanced bioavailability of specific drugs?
. - Research on dried emulsion/mannitol composite microparticles for tuberculosis treatment, showcasing advanced delivery methods for challenging diseases?
- Development of two-step sustained-release PLGA/hyaluronic acid gel formulations for intra-articular administration, focusing on improving therapeutic outcomes for knee conditions?